-+ 0.00%
-+ 0.00%
-+ 0.00%

Nuvectis Pharma Q2 EPS $(0.30) Misses $(0.26) Estimate

Benzinga·08/04/2026 12:03:29
Listen to the news
Nuvectis Pharma (NASDAQ:NVCT) reported quarterly losses of $(0.30) per share which missed the analyst consensus estimate of $(0.26) by 15.38 percent. This is unchanged from the same period last year.